Thus, maintaining LMX1A/LMX1B in the adult brain is likely to be important for protection against PD-associated mDAN decline, while boosting expression and/or activities of these transcription factors may be of therapeutic benefit. This evidence concerns the gene LMX1B and Parkinson disease.